Literature DB >> 1497624

Characterization of proteoglycan degradation by calpain.

K Suzuki1, K Shimizu, T Hamamoto, Y Nakagawa, T Murachi, T Yamamuro.   

Abstract

Degradation of cartilage proteoglycans was investigated under neutral conditions (pH 7.5) by using pig kidney calpain II (EC 3.4.22.17; Ca(2+)-dependent cysteine proteinase). Aggregate and monomer degradation reached a maximum in 5 min at 30 degrees C when the substrate/enzyme ratio was less than 1000:1. The mode of degradation was limited proteolysis of the core protein; the size of the products was larger than that of papain-digested products and comparable with that of trypsin-digested products. The hyaluronic acid-binding region was lost from the major glycosaminoglycan-bearing region after incubation with calpain II. Calpains thus may affect the form of proteoglycans in connective tissue. Ca(2+)-dependent proteoglycan degradation was unique in that proteoglycans adsorb large amounts of Ca2+ ions rapidly before activation of calpain II: 1 mg of pig cartilage proteoglycan monomer adsorbed 1.3-1.6 mu equiv. of Ca2+ ions before activation of calpain II, which corresponds to half the sum of anion groups in glycosaminoglycan side chains. This adsorption of Ca2+ was lost after solvolysis of proteoglycan monomer with methanol/50 mM-HCl, which was used to desulphate glycosaminoglycans. Therefore cartilage proteoglycans are not merely the substrates of proteolysis, but they may regulate the activation of Ca(2+)-dependent enzymes including calpains through tight chelation of Ca2+ ions between glycosaminoglycan side chains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497624      PMCID: PMC1132875          DOI: 10.1042/bj2850857

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  A photometric assay for protease digestion of the proteoglycan subunit.

Authors:  A I Sapolsky; J F Woessner; D S Howell
Journal:  Anal Biochem       Date:  1975-08       Impact factor: 3.365

2.  Biochemical demonstration of calpains and calpastatin in osteoarthritic synovial fluid.

Authors:  K Suzuki; K Shimizu; T Hamamoto; Y Nakagawa; T Hamakubo; T Yamamuro
Journal:  Arthritis Rheum       Date:  1990-05

3.  Cartilage proteoglycan depletion in acute and chronic antigen-induced arthritis.

Authors:  E R Pettipher; B Henderson; T Hardingham; A Ratcliffe
Journal:  Arthritis Rheum       Date:  1989-05

4.  Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ.

Authors:  Q Nguyen; G Murphy; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

5.  Assay of proteoglycan populations using agarose-polyacrylamide gel electrophoresis.

Authors:  D Heinegård; Y Sommarin; E Hedbom; J Wieslander; B Larsson
Journal:  Anal Biochem       Date:  1985-11-15       Impact factor: 3.365

6.  High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s).

Authors:  A H Schmaier; P M Smith; A D Purdon; J G White; R W Colman
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

7.  Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease.

Authors:  S D Berkowitz; H Nozaki; K Titani; T Murachi; E F Plow; T S Zimmerman
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

8.  Binding of calcium by proteoglycans in vitro.

Authors:  D D Dziewiatkowski
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

9.  The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis.

Authors:  P J Roughley; A J Barrett
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

10.  Binding of calcium to glycosaminoglycans: an equilibrium dialysis study.

Authors:  G K Hunter; K S Wong; J J Kim
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

View more
  6 in total

1.  Autoantibodies directed against the protease inhibitor calpastatin in psoriasis.

Authors:  Y Matsushita; Y Shimada; S Kawara; K Takehara; S Sato
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  Hypothesis: an amino acid sequence in lipoprotein lipase codes for its degradation by Ca(2+)-dependent proteases.

Authors:  A Boivin; Y Deshaies
Journal:  Lipids       Date:  1995-01       Impact factor: 1.880

3.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice.

Authors:  Z Szomor; K Shimizu; Y Fujimori; S Yamamoto; T Yamamuro
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.

Authors:  T Mimori; K Suganuma; Y Tanami; T Nojima; M Matsumura; T Fujii; T Yoshizawa; K Suzuki; M Akizuki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

6.  Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals.

Authors:  Mikiko Iguchi-Hashimoto; Takashi Usui; Hajime Yoshifuji; Masakazu Shimizu; Shio Kobayashi; Yoshinaga Ito; Kosaku Murakami; Aoi Shiomi; Naoichiro Yukawa; Daisuke Kawabata; Takaki Nojima; Koichiro Ohmura; Takao Fujii; Tsuneyo Mimori
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.